23 May 2018
News and Views
Links and Services
This week's New England Journal of Medicine compares telbivudine with lamivudine in patients with chronic Hep B.
Reducing Hepatitis B virus replication to minimal levels is emerging as a key therapeutic goal fo
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors